• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Robert King

    Robert King

    Mylan CEO Heather Bresch in her opening statement will attempt to shift focus to access provided to allergy patients. (Andrew Harrer/Bloomberg)
    Healthcare

    CEO not expected to offer more discounts for EpiPen

    Robert King -
    September 21, 2016 4:01 am
    0
    The Senate Finance Committee wrote to the Obama administration on Tuesday to examine whether there is enough oversight of the Medicaid Drug Rebate Program, after concerns that Mylan allegedly manipulated the program to avoid having to pay a higher rebate. (Daniel Acker/Bloomberg)
    Healthcare

    Senators seek probe of EpiPen rebates

    Robert King -
    September 20, 2016 8:43 pm
    0
    Over the past nine years, Medicare spending on EpiPens has increased by 1,151 percent. (Daniel Acker/Bloomberg)
    Healthcare

    Medicare spending on EpiPens rose past 1,000 percent

    Robert King -
    September 20, 2016 8:08 pm
    0
    This illustration made available by the Centers for Disease Control and Prevention shows the Shigella bacteria. On Thursday, April 2, 2015, the CDC said a drug-resistant strain of a stomach bug made its way into the U.S. and spread, causing more than 200 illnesses since last May. Many cases were traced to people who had recently traveled to the Dominican Republic, India or other countries. (AP Photo/CDC)
    Healthcare

    UN to hold rare, major meeting on superbug threat

    Robert King -
    September 20, 2016 4:01 am
    0
    lorida Gov. Rick Scott announced Monday that it has been 45 days since the last Zika infection was found in the Wynwood neighborhood, the Associated Press reported. (AP Photo)
    Healthcare

    Zika no longer spreading in Miami neighborhood

    Robert King -
    September 19, 2016 3:00 pm
    0
    The FDA approved the Exondys 51 injection to treat patients with Duchenne muscular dystrophy, a condition that primarily affects boys and quickly reduces motor function. (AP Photo)
    Healthcare

    After pressure, FDA approves drug for rare disease

    Robert King -
    September 19, 2016 2:56 pm
    0
    White House pushes for opioid funding this week
    Healthcare

    White House pushes for opioid funding this week

    Robert King -
    September 19, 2016 2:14 pm
    0
    A new analysis found 2016 Obamacare premiums for the silver plan were lower in 39 states and the District of Columbia than the average premium for employer-sponsored plans. (AP Photo)
    Healthcare

    Report: Obamacare premiums cost less than employer plans

    Robert King -
    September 19, 2016 7:00 am
    0
    About 21 percent of clinical trials for cancer are not completed because of low participation. (iStock Photo)
    Healthcare

    White House wants patients to find life-saving drug trials

    Robert King -
    September 16, 2016 3:15 pm
    0
    House Republicans called for a federal watchdog to examine the National Institutes of Health's role in a controversy surrounding grants for brain research. (AP Photo/Paul Sancya)
    Healthcare

    House Republicans target NIH, not NFL, over brain research

    Robert King -
    September 15, 2016 7:27 pm
    0
    1...227228229...357Page 228 of 357
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.